Zydus Cadila gets USFDA nod for anti-diabetics tablets
Drug firm Zydus Cadila has received final nod from the US health regulator to sell anti-diabetics Glyburide and Metformin Hcl tablets in the American market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 1, 2016 Category: Pharmaceuticals Source Type: news
GAMES-RP: Can Glyburide Reduce Edema in Severe Stroke? GAMES-RP: Can Glyburide Reduce Edema in Severe Stroke?
A new IV formulation of the generic diabetes drug shows some promising effects on exploratory endpoints in a phase 2 study of patients with large hemispheric stroke. Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 24, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Cancer Risk Elevated With Glyburide Over Other Sulfonylureas Cancer Risk Elevated With Glyburide Over Other Sulfonylureas
Overall cancer risk with glyburide was not significantly elevated, but significant dose- and duration-response relationships were seen with glyburide and breast, prostate, and colorectal cancers. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 14, 2015 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
glyburide/metformin (Glucovance)
Title: glyburide/metformin (Glucovance)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 8/20/2015 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - August 20, 2015 Category: Endocrinology Source Type: news
Diabetes Tx Ups Risk for Poor Neonatal Outcomes (CME/CE)
(MedPage Today) -- Study heightens residual concerns about use of glyburide to treat gestational diabetes. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 1, 2015 Category: Cardiology Source Type: news
Glyburide Tied to Greater Neonatal Risk Than Insulin in GDMGlyburide Tied to Greater Neonatal Risk Than Insulin in GDM
The largest study to date of glyburide vs insulin for gestational diabetes identifies an increased risk of adverse neonatal outcomes with glyburide; however, insulin may not be best for all women. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 1, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Glyburide Treatment for Gestational Diabetes Associated with Adverse Newborn Health Effects (FREE)
By Jenni Whalen Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Treating gestational diabetes with glyburide, rather than insulin, is associated with increased risk for adverse outcomes in newborns, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 31, 2015 Category: Primary Care Source Type: news
Gestational Diabetes Drug Might Raise Babies' Complication Risk
Study links glyburide to more infant intensive care and respiratory distress (Source: WebMD Health)
Source: WebMD Health - March 30, 2015 Category: Consumer Health News Source Type: news
Gestational Diabetes Drug Might Raise Babies' Complication Risk
Study links glyburide to more infant intensive care and respiratory distress
Source: HealthDay
Related MedlinePlus Pages: Diabetes and Pregnancy, Pregnancy and Medicines, Uncommon Infant and Newborn Problems (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 30, 2015 Category: Consumer Health News Source Type: news
Short-Term Outcomes Worse With Glyburide for GDMShort-Term Outcomes Worse With Glyburide for GDM
Glyburide (glibenclamide) should not be used to treat gestational diabetes mellitus (GDM) unless insulin and metformin are unavailable, the authors of a new systematic review and meta-analysis conclude. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 2, 2015 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Glyburide Seems a Poor Choice in Gestational Diabetes (FREE)
By Joe Elia
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The oral agent glyburide is "clearly inferior" to both metformin and insulin in gestational diabetes outcomes, a BMJ meta-analysis … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 23, 2015 Category: Primary Care Source Type: news
glyburide
Title: glyburideCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/29/2014 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - October 29, 2014 Category: Endocrinology Source Type: news
glyburide
Title: glyburideCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/29/2014 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 29, 2014 Category: Drugs & Pharmacology Source Type: news
Common heart drug's link to diabetes uncovered by researchers
Statins activated a very specific immune response, which stopped insulin from doing its job properly, researchers have found. They connected the dots and found that combining statins with another drug on top of it, Glyburide, suppressed this side effect. Approximately 13 million people, or half of those over the age of 40, could be prescribed a statin drug in their lifetime. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 11, 2014 Category: Science Source Type: news
